tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VERA Stock Latest News

Vera Therapeutics Reports Progress in Clinical Trials
Company AnnouncementsVera Therapeutics Reports Progress in Clinical Trials
23d ago
VERA
Vera Therapeutics Signs New Sales Agreement with TD Securities
PremiumCompany Announcements
Vera Therapeutics Signs New Sales Agreement with TD Securities
24d ago
8K
VERA
Vera Therapeutics reports Q2 EPS ($1.20), consensus (62c)
PremiumThe Fly
Vera Therapeutics reports Q2 EPS ($1.20), consensus (62c)
24d ago
VERA
Vera Therapeutics announces anticipated upcoming milestones
PremiumThe Fly
Vera Therapeutics announces anticipated upcoming milestones
24d ago
VERA
Vera Therapeutics sees cash funding operations through launch of atacicept
PremiumThe Fly
Vera Therapeutics sees cash funding operations through launch of atacicept
24d ago
VERA
Tesla grants Musk big payout, Wayfair reports Q2 beat: Morning Buzz
PremiumThe FlyTesla grants Musk big payout, Wayfair reports Q2 beat: Morning Buzz
25d ago
W
BA
Coinbase downgraded, Spotify upgraded: Wall Street’s top analyst calls
Premium
The Fly
Coinbase downgraded, Spotify upgraded: Wall Street’s top analyst calls
25d ago
AVB
BAX
Vera Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
Premium
The Fly
Vera Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
25d ago
VERA
Millions in Insider Buying Point to These 2 Stocks — Here’s What It Could Signal
PremiumStock Analysis & Ideas
Millions in Insider Buying Point to These 2 Stocks — Here’s What It Could Signal
2M ago
VAC
VERA
Vera Therapeutics Inc put volume heavy and directionally bearish
PremiumThe Fly
Vera Therapeutics Inc put volume heavy and directionally bearish
2M ago
VERA
Vera Therapeutics Inc call volume above normal and directionally bullish
PremiumThe Fly
Vera Therapeutics Inc call volume above normal and directionally bullish
3M ago
VERA
3 Best Stocks to Buy Now, 6/9/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 6/9/2025, According to Top Analysts
3M ago
HIVE
TALO
U.S. payrolls rise 139,000, Broadcom reports Q2 beat: Morning Buzz
PremiumThe FlyU.S. payrolls rise 139,000, Broadcom reports Q2 beat: Morning Buzz
3M ago
DE
ZM
Vera Therapeutics drops 30% after rival Otsuka presents Phase 3 data
Premium
The Fly
Vera Therapeutics drops 30% after rival Otsuka presents Phase 3 data
3M ago
VERA
Buy Rating for Vera Therapeutics: Promising Atacicept Data and Market Potential in IgAN Treatment
Premium
Ratings
Buy Rating for Vera Therapeutics: Promising Atacicept Data and Market Potential in IgAN Treatment
3M ago
VERA
3 Best Stocks to Buy Now, 6/4/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 6/4/2025, According to Top Analysts
3M ago
APP
BRZE
Vera Therapeutics price target raised to $65 from $55 at Scotiabank
PremiumThe Fly
Vera Therapeutics price target raised to $65 from $55 at Scotiabank
3M ago
VERA
Vera Therapeutics: Promising Phase III Results and Strategic Positioning Justify Buy Rating
PremiumRatings
Vera Therapeutics: Promising Phase III Results and Strategic Positioning Justify Buy Rating
3M ago
VERA
Vera Therapeutics Secures $500M Loan Agreement
PremiumCompany Announcements
Vera Therapeutics Secures $500M Loan Agreement
3M ago
8K
VERA
Vera Therapeutics price target raised to $65 from $61 at Guggenheim
PremiumThe FlyVera Therapeutics price target raised to $65 from $61 at Guggenheim
3M ago
VERA
Vera Therapeutics price target raised to $65 from $55 at Scotiabank
Premium
The Fly
Vera Therapeutics price target raised to $65 from $55 at Scotiabank
3M ago
VERA
Buy Rating for Vera Therapeutics: Promising Potential of Atacicept in IgA Nephropathy Treatment
Premium
Ratings
Buy Rating for Vera Therapeutics: Promising Potential of Atacicept in IgA Nephropathy Treatment
3M ago
VERA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >